Treatment of patients with severe somatic disease. Patients
with cardiovascular, cerebrovascular and endocrine
disease may have adequate and reasonable anxiety
reactions associated with their somatic disease state.
They may also suffer from comorbid primary anxiety
disorders. Such anxiety disorders are believed to
compound the management and the prognosis of
chronic obstructive pulmonary disease, coronary
artery disease or myocardial infarction, diabetes mellitus
or brain injury. Anxiety symptoms may also be
a consequence of medical conditions, such as hyperthyroidism.